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Available online 22 July 2017Human induced pluripotent stem cell (iPSC) line was generated from ﬁbroblasts of a patient with propionic
acidemia carrying mutations in the PCCA gene: c.1899+4_1899+7delAGTA; p.(Cys616_Val633del) and
c.1430−−?_1643+?del; p.(Gly477Glufs*9). Reprogramming factors OCT3/4, SOX2, KLF4 and c-MYCwere deliv-
ered using a non-integrative method based on the Sendai virus. Once established, iPSCs have shown full
pluripotency, differentiation capacity and genetic stability.lar Sever
9 Madri
. This is©2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Resource tablenique stem cell line
identiﬁerUAMi001-Alternative name of
stem cell linePCCA23-FiPS4F8stitution Centro de Biología Molecular Severo Ochoa UAM-CSIC,
Universidad Autónoma de Madrid, CIBERER, IDIPaz,
Madrid, Spainerson who created
resourceEsmeralda Alonso-Barroso, Eva Richardontact person and
emailEva Richard, erichard@cbm.csic.esate archived/stock
dateSeptember 17, 2016rigin Human skin cells
pe of resource Biological reagent: induced pluripotent stem cells (iPSC);
derived from a patient with propionic acidemia due to
defects in the PCCA geneb-type Human iPSC line
ey transcription
factorsOCT3/4, SOX2, c-MYC, KLF4 (CytoTune®-iPS 2.0 Sendai
Reprogramming Kit; Invitrogen by Life Technologies)uthentication Identity and purity of cell line conﬁrmed (Fig. 1)
nk to related
literatureNot availableell line
repository/bankNot applicablethics Patient informed consent obtained/Ethics Review
Board-competent authority approval obtainedo Ochoa UAM-CSIC, C/
d, Spain.
an open access article underResource utility
This iPSC line was generated to differentiate into cardiomyocytes
and neurons and obtain new disease models. We will investigate the
pathophysiology of propionic acidemia disease and evaluate the effects
of therapeutic compounds such as antioxidants.
Resource details
Propionic acidemia (PA) is an inherited metabolic disease caused by
mutations in either the PCCA or PCCB genes (Richard et al., 2015).
Fibroblasts from a compound heterozygous PA patient carrying twomuta-
tions in thePCCAgene (c.1899+4_1899+7delAGTA;p.(Cys616_Val633del)
and c.1430−−?_1643+?del; p.(Gly477Glufs*9)) (Desviat et al., 2009)
were reprogrammed using the CytoTune™ iPS 2.0 Sendai Reprogramming
kit delivering the four human reprogramming factors OCT3/4, SOX2, c-MYC
andKLF4 (Takahashi et al., 2007). The iPSC line PCCA23-FiPS4F8 (UAMi001-
A)displayed a typical round shapeESC-likemorphology andgrowthbehav-
iour (Fig. 1A) and the colonies stained positive for alkaline phosphatase ac-
tivity (Fig. 1B). The clearance of the vectors and the exogenous
reprogramming factor genes was observed by RT-PCR after 8 culture pas-
sages (Fig. 1C). Mycoplasma testing by a colorimetry assay revealed a neg-
ative result (Supplementary Fig. S1A). To analyze the genetic stability, we
conﬁrmed the presence of the twomutations in the iPSC line by Sanger se-
quencing (c.1899+4_1899+7delAGTA; p.(Cys616_Val633del) and multi-
plex ligation probe ampliﬁcation (MLPA) analysis (c.1430−?_1643+?del;
p.(Gly477Glufs*9)) revealing exons 17–18 deletion (Fig. 1D); and we also
conﬁrmed by DNA ﬁngerprinting analysis that the line was derived fromthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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displayed a normal karyotype (46, XX) aftermore than twenty culture pas-
sages (Fig. 1E). Expression of key pluripotency genes was observed both at
RNA level (transcription factors OCT4, SOX2, REX1, NANOG, CRIPTO andKLF4) by qRT-PCR (Fig. 1F), as well as at protein level (transcription factors
OCT4, NANOG and SOX2, and surfacemarkers SSEA3, SSEA4, TRA-1-60 and
TRA-1-81) by immunocytochemistry (Fig. 1G) and ﬂow cytometry analysis
(Fig. 1H). In addition, methylation analysis of the promoters of the
175E. Alonso-Barroso et al. / Stem Cell Research 23 (2017) 173–177pluripotency associated genes, OCT4 andNANOG, revealed a heavymethyl-
ation in the original ﬁbroblasts and an almost complete demethylation in
the iPSC line (Fig. 1I). Finally, the cells had the capacity to form derivatives
of all threegerm layers (endoderm,mesodermandectoderm)uponembry-
oid body differentiation (Fig. 1J, Table 1).Materials and methods
Non-integrative reprogramming of mutant PCCA ﬁbroblasts into iPSC
The present study included available ﬁbroblasts from a PA patient
with defects in the PCCA gene. Experimental protocols were approved
by the Institutional Ethical Committee of the Universidad Autónoma
deMadrid according to Spanish and European Union legislation, and in-
formed consent was obtained from the legal care-givers. Patient-de-
rived ﬁbroblasts were cultured under standard conditions in MEM
supplementedwith 10% fetal bovine serum, 200mMglutamine and an-
tibiotics. Fibroblasts were reprogrammed using the CytoTune™ iPS 2.0
Sendai Reprogramming kit (Life Technologies) following the
manufacturer's instructions. iPSCs were maintained and expanded
both on feeder layers and on feeder-free layers. In the ﬁrst case,
human ﬁbroblasts feeders were mitotically inactivated by gamma irra-
diation (80 Gy). iPSCs were cultured on top of irradiated human ﬁbro-
blasts changing every day the iPSC medium containing: knockout
DMEM (Life Technologies), 10% knockout serum replacement (Life
Technologies), 0.5% human serum albumin (Grifols), 2 mM Glutamax
™ (Life Technologies), 100 μM non-essential amino acids (Lonza), 100
μM β-mercaptoethanol (Life Technologies), 50 U/ml penicillin,
50 mg/ml streptomycin (Life Technologies) and 10 ng/ml bFGF
(Peprotech). For the propagation of iPSC, mechanical procedures were
applied using a “stripper” micropipette and 150 μm tips (Mid Atlantic)
to carefully lift and aspirate the colony. iPSC were also adapted and cul-
tured in feeder-free conditions on Matrigel® (Corning) using iPSC con-
ditioned medium and, in this case, for the iPSC propagation the
enzymatic procedure StemPro® accutase® (Gibco by Life Technologies)
was used. iPSC conditioned medium was obtained from feeder layers,
supplemented with 10 ng/ml bFGF and ﬁltered.Phosphatase alkaline analysis
iPSC colonies were picked and plated onto a P-100 plate with
feeders. After six days, direct phosphatase alkaline activity was deter-
mined using the Phosphatase Alkaline Blue Membrane Substrate Solu-
tion kit (Sigma-Aldrich) following manufacturer's instructions.Detection of Sendai virus genome and transgenes
After 8 passages, iPSC linewas tested for Sendai virus (SeV) residues.
Total RNAwas isolated using TRIzol® Reagent (Life Technologies) and 1
μg of RNA was retrotranscribed using NZY First-Strand cDNA Synthesis
kit (NZY Tech). RNA from the transduced cell pool at passage zero was
used as positive control. PCRwas performed using the primers indicated
in Table 2 and following the instructions as recommended by the
manufacturer.Fig. 1. Generation and molecular and functional characterization of the PCCA23-FiPS4F8 iPSC
reprogramming. (B) Alkaline phosphatase enzymatic activity staining (right) and unstained
and Sendai virus vectors. C+: transduced cell pool at passage zero; C–: non-templa
p.(Cys616_Val633del) (top) and MLPA analysis showing the deletion of exons 17 and 18 (
analysis. (F) qPCR showing the relative gene expression of the endogenous pluripotency ass
analysis with typical embryonic stem cell markers such as transcription factors OCT4, NANOG
μm. (H) Expression analysis of pluripotent markers (SSEA4, TRA-1-81 and TRA-1-60) by ﬂow
horizontal row of circles represents the methylation status of each CpG in one clone. Ope
Immunoﬂuorescence analysis with speciﬁc markers of all three primary germ layers after in
ectoderm: β-III-Tubulin Tuj1; scale bars: 50 μm.Mutation analysis
Genomic DNA from the patient-derived ﬁbroblasts and iPSCs was
isolated using MagNA Pure Compact DNA Isolation kit and MagNA
Pure Compact instrument (Roche). Subsequently, ampliﬁcation by PCR
of the PCCA region containing the c.1899+4_1899+7delAGTA;
p.(Cys616_Val633del) mutation was carried out using the primers indi-
cated in Table 2, and ampliﬁed PCR fragments were sequenced in an
ABI3730 sequencer (Applied Biosystems). Detection of c.1430−
?_1643+?del; p.(Gly477Glufs*9) mutation was performed using the
SALSAMLPA P278-C1-PCCA probemix (MRC-Holland) for copy number
detection.Karyotype analysis
Karyotype analysis of the iPSC line was carried out using cells with
more than twenty culture passages which were processed using stan-
dard cytogenetic techniques. Brieﬂy, cells were treated with 10 μg/ml
of Colcemid® Solution (Irvine Scientiﬁc) for 90min at 37 °C, dissociated
by accutase, treated with hypotonic solution and ﬁxed with Carnoy's
ﬁxative. Cells were then dropped on a microscope glass slide and
dried. Metaphase cells were G banded using Wright staining. At least
20 metaphases were karyotyped. Karyotype analysis was performed at
Instituto de Genética Médica y Molecular del Hospital Universitario de
La Paz, Madrid, Spain.Quantitative PCR analysis
Total RNA from the ﬁbroblasts and iPSCs was isolated using TRIzol®
Reagent (Life Technologies). RT-PCR was performed using High Capaci-
ty RNA to cDNA kit (Applied Biosystems), and real-time PCR was per-
formed using SYBR® Green Master Mix (Applied Biosystems) and
LightCycler 480 instrument (Roche), at Parque Cientíﬁco de Madrid,
Campus de Cantoblanco, UAM, Madrid, Spain. Ampliﬁcation efﬁciency
and sample-to-sample variation were normalized by monitoring
GAPDH. The expression levels of several pluripotency associated genes
(OCT4, SOX2, REX1, NANOG, CRIPTO and HLF4) were quantiﬁed. Primer
sequences were described by (Aasen et al., 2008) (Table 2).Immunoﬂuorescence analysis
iPSC were grown on feeder layers on 15 μ-Slide 8 well culture plates
(Aasen et al., 2008) and ﬁxed with Formaline Solution 10% (Sigma-Al-
drich). The following antibodies were used: TRA-1-60 (Millipore;
MAB4360; 1:200); TRA-1-81 (Millipore; MAB4381; 1:200); SOX2
(Thermo Scientiﬁc, PA1-16968, 1:100); NANOG (RD Systems, AF1997,
1:25); SSEA-4 (DSHB, MC-813-70, 1:3); SSEA-3 (DSHB, MC-631, 1:3);
OCT4 (Santa Cruz Biotechnology, sc-5279, 1:60); β-III Tubulin Tuj1
(Covance, MMS-435P, 1:500); α-1 Fetoprotein (Dako, A0008, 1:400);
α-Smooth muscle actin (Sigma-Aldrich, A5228, 1:400) (Table 2). Sec-
ondary antibodies used were from Alexa Fluor Series from Jackson
Immunoresearch, Thermo Fisher Scientiﬁc and Invitrogen (1:200)
(Table 2). For nucleus staining DAPI (Invitrogen, 1:10,000) was used.
Images were taken using a Zeiss confocal microscope.line. (A) Typical embryonic stem cell-like colony morphology obtained after ﬁbroblasts
iPS colony (left). (C) RT-PCR for the detection of the exogenous reprogramming factors
te control. (D) Electropherogram showing mutation c.1899+4_1899+7delAGTA;
mutation c.1430−?_1643+?del; p.Gly477fs) (bottom) of the iPSC line. (E) Karyotype
ociated markers OCT4, SOX2, REX1, NANOG, CRIPTO and KLF4. (G) Immunoﬂuorescence
and SOX2, and surface markers SSEA3, TRA-1-81, SSEA4 and TRA-1-60; scale bars: 100
cytometry analysis. (I) Bisulﬁte sequencing analysis of OCT4 and NANOG promoters. Each
n circles indicate unmethylated CpG dinucleotides and ﬁlled circles, methylated. (J)
vitro differentiation. Endoderm: α-1-Fetoprotein; mesoderm: α-Smooth muscle actin;
Table 1
Characterization and validation.
Classiﬁcation Test Result Data
Morphology Photography Visual record of the line: normal Fig. 1 panel A
Phenotype Immunocytochemistry Assess staining/expression of pluripotency and cell surface markers: OCT4, NANOG, SOX2,
SSEA3, TRA-1-81, SSEA4 and TRA-1-60
Fig. 1 panel G
Flow cytometry Assess staining/expression of pluripotency markers: SSEA4, TRA-1-60, TRA-1-81 Fig. 1 panel H
Genotype Karyotype (G-banding) and
resolution
46XX, Resolution 450–500 Fig. 1 panel E
Identity Microsatellite PCR (mPCR) Not performed
STR analysis 16 sites tested and all of them matched Supplementary Fig. 1
panel B
Mutation analysis (IF
APPLICABLE)
Sequencing and MLPA
analysis
c.1899+4_1899+7del AGTA; p.(Cys616_Val633del) and c.1430−?_1643+?del;
p.(Gly477Glufs*9)
Fig. 1 panel D
Southern Blot OR WGS Not performed
Microbiology and virology Mycoplasma Mycoplasma testing by a colorimetric assay: negative Supplementary Fig. 1
panel A
Differentiation potential Embryoid body formation Expression of smooth muscle actin, β-III-tubulin Tuj1 and α− 1 fetoprotein Fig. 1 panel J
Donor screening
(OPTIONAL)
HIV 1 + 2 Hepatitis B,
Hepatitis C
Not performed
Genotype additional info
(OPTIONAL)
Blood group genotyping Not performed
HLA tissue typing Not performed
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We analysed the pluripotency-associated markers SSEA4, TRA-1-60
and TRA-1-81 by ﬂow cytometry. iPSC were dissociated by incubation
with accutase for 5 min. Then, cells were suspended in PBS/2%BSA to a
cell density of 1.5 × 105 cells per 100 μl and incubated with the speciﬁc
primary antibody (1/100 for TRA-1-60 and TRA-1-81, and no dilution
for SSEA4) for 20 min at 4 °C. Cells were washed with PBS/2%BSA and
incubated with Alexa Fluor® 647 (1/600) for 20 min at 4 °C. Finally,
cells were washed with PBS/2%BSA and analysed using a FACSCanto A
(Becton Dickinson) and FlowJo 10.2 software program. An irrelevant
isotype-match antibody was always used as a negative control.Table 2
Reagents details.
Antibodies used for immunocytochemistry
Antibody
Pluripotency markers Mouse IgG anti-OCT4
Rat IgM anti-SSEA3
Rabbit IgG anti-SOX2
Mouse IgG anti-SSEA4
Mouse IgM anti-TRA-1-60
Goat IgG anti-NANOG human
Mouse IgM anti-TRA-1-81
Differentiation markers Rabbit IgG anti-α-Fetoprotein
Mouse IgG anti-β-III-Tubulin Tuj1
Mouse IgG anti-α-smooth muscle act
Secondary antibodies Alexa 555 Donkey anti-Mouse IgG
Alexa 488 Goat anti-Rat IgM
Alexa 488 Donkey anti-Rabbit IgG
Alexa 555 Donkey anti-Mouse IgG
Alexa 647 Goat anti-Mouse IgM
Alexa 647 Donkey anti-Goat IgG
Alexa 55 Donkey anti-Mouse IgM Cy3
Primers
Target
Reverse transcription-PCR SeV genome
KOS transgene
KLF4 transgene
c-MYC transgene
Pluripotency Markers (Qpcr) OCT4
SOX2
NANOG
CRIPTO
REX1
KLF4
House-keeping genes (qPCR) GAPDH
Targeted mutation analysis/sequencing (PCR) PCCA-exon 21Bisulﬁte sequencing
Bisulﬁte modiﬁcation of genomic DNA was performed with EZ DNA
Methylation-Gold™ kit (Zymo Research) following the manufacturer's
instructions. Converted DNA was ampliﬁed by PCR using primers previ-
ously published (Freberg et al., 2007) and Immolase™ RedDNA Polymer-
ase (Bioline). PCR conditions were 95 °C for 8 min and 40 cycles of 94 °C
for 1min, 58 °C for 1min and 72 °C for 1min, followed by 10min at 72 °C.
PCR products were cloned into bacteria by pGEM®-T Easy Vector
(Promega) and sequenced using T7 primer. Sequences of 5 bacterial
clones per genomic region examined are represented as rows of circles
in Fig. 1H with each circle symbolizing the methylation state of one CpG.Dilution Company Cat# and RRID
1:60 Santa Cruz Cat# sc-5279, AB_628051
1:3 Hybridoma Bank Cat# MC-631, AB_528476
1:100 Fisher Thermo Scientiﬁc Cat# PA1-16968, AB_2195781
1:3 HYBRIDOMA Bank Cat# MC-813-70, AB_528477
1:200 Millipore Cat# MAB4360, AB_2119183
1:25 R&D Cat# AF1997, AB_355097
1:200 Millipore Cat# MAB4381, AB_177638
1:400 Dako Cat# A0008, AB_2650473
1:500 Covance Cat# MMS-435P, AB_231377
in 1:400 Sigma-Aldrich Cat# A5228, AB_262054
1:200 Thermo Fischer Cat# A-31570, AB_2536180
1:200 Thermo Fischer Cat# A-21212, AB_2535798
1:200 Thermo Fischer Cat# A-31572, AB_162543
1:200 Thermo Fischer Cat# A-31570, AB_2536180
1:200 Thermo Fischer Cat# A-21238, AB_2535807
1:200 Thermo Fischer Cat# A-21447, AB_2535864
1:200 Jackson Cat# 715-165-140,
Forward/Reverse primer (5′-3′)
GGATCACTAGGTGATATCGAGC/ACCAGACAAGAGTTTAAGAGATATGTATC
ATGCACCGCTACGACGTGAGCGC/ACCTTGACAATCCTGATGTGG
TTCCTGCATGCCAGAGGAGCCC/AATGTATCGAAGGTGCTCAA
TAACTGACTAGCAGGCTTGTCG/TCCACATACAGTCCTGGATGATGATG
GGAGGAAGCTGACAACAATGAAA/GGCCTGCACGAGGGTTT
TGCGAGCGCTGCACAT/TCATGAGCGTCTTGGTTTTCC
ACAACTGGCCGAAGAATAGCA/GGTTCCCAGTCGGGTTCAC
CGGAACTGTGAGCACGATGT/GGGCAGCCAGGTGTCATG
CCTGCAGGCGGAAATAGAAC/GCACACATAGCCATCACATAAGG
CGAACCCACACAGGTGAGAA/GAGCGGGCGAATTTCCAT
GCACCGTCAAGGCTGAGAAC/AGGGATCTCGCTCCTGGAA
TTGATGGACATTTGGGTTTTT/AGCAGTAATGAAGCCAAGTTCA
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To perform in vitro differentiation analysis, iPSC colonies were ﬁrst
cultured in suspension so that they form large aggregates called embry-
oid bodies (EBs). EBs differentiate spontaneously to different cell types
derived from the three germ layers. iPSCs from a P100 plate treated
with matrigel (80% conﬂuency) were dissociated into a single cell sus-
pension with accutase, and resuspended in 12 ml of conditioned medi-
um. EBs formationwas induced by seeding 120 μl of the iPSC suspension
in each well of 96-well v-bottom low attachment plates, and by
centrifuging the plates at 800g for 10 min to aggregate the cells. After
2 days, the EBs were transferred to untreated P60 culture plates for
2 days. Subsequently, the EBs were transferred to 15 μ-Slide 8 well cul-
ture plates previously treated with matrigel for 1 h at room tempera-
ture, and cultured in differentiation medium (DMEM supplemented
with 20% fetal bovine serum, 2 mM Glutamax™, 100 μM non-essential
amino acids, 100 μM β-mercaptoethanol, and 50 U/ml penicillin,
50mg/ml streptomycin) for 2–3weeks to allow spontaneous endoderm
formation. For mesoderm differentiation, EBs were maintained for 2–
3weeks in differentiationmedium supplementedwith 100 μMascorbic
acid (A4403, Sigma-Aldrich). For ectoderm differentiation, EBs were
cultured in a special differentiation medium containing (50% DMEM
F12, 50% neurobasal medium, 2 mM Glutamax™, 1× N2 supplement,
1× B27 supplement and 50 U/ml penicillin, 50 mg/ml streptomycin,
all from Gibco by Life Technologies) for 2–3 weeks. In all cases, the me-
dium was changed every two days.
Mycoplasma detection
Cells were screened for mycoplasma contamination using a colori-
metric assay, PlasmoTest™Mycoplasma Detection Kit (InvivoGen), fol-
lowing the manufacturer's protocol.
DNA ﬁngerprinting analysis
DNA ﬁngerprinting analysis was performed using the AmpFLSTR®
Identiﬁler® PCR Ampliﬁcation Kit (Thermo Fisher Scientiﬁc). A total of
1 ng of DNA was used and highly polymorphic regions containingshort tandem repeated sequences were evaluated by the ampliﬁcation
of the following markers (D8S1179, D21S11, D7S820, CSF1P0,
D3S1358, TH01, D13S317, D16S539, D2S1338, D19S433, vWA, TPOX,
D18S51, D5S818, FGA and Amelogenin for sex determination) by PCR.
Samples were run on a 3730 DNA Analyzer (Applied Biosystems) and
the analysis was performed usingGeneMapper® v4.0, at Parque Científ-
ico de Madrid, Campus Moncloa, UCM, Madrid, Spain.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2017.07.021.
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